Clinical trial data

Medicines and vaccines have helped deliver incredible improvements in patient health. This section looks at expenditure on R&D in the UK and around the world, clinical trials by phase and by therapy area and research intensity.

Number of commercial clinical trials started in the UK, by year and phase (2012-2018)

Number of commercial clinical trial applications received by MHRA, by year (2013-2018)

Number of clinical trial applications received by MHRA in 2018, by phase and sponsor type

Number of commercial clinical trials started by country, Phase I (2012-2018)

Number of commercial clinical trials started by country, Phase II (2012-2018)

Number of commercial clinical trials started by country, Phase III (2012-2018)

Number of commercial clinical trials started in the UK, by year and disease area (2012-2018)

Number of commercial clinical trials started in oncology, by year and country (2012-2018)

Number of commercial clinical trials started in cardio-metabolic diseases, by year and country (2012-2018)

Number of commercial clinical trials started in nervous system diseases, by year and country (2012-2018)

Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)

Number of commercial clinical trials started in infectious diseases, by year and country (2012-2018)